Poster Session 1: Histocompatibility/Alternative Stem Cell Sources
Poster Abstracts
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)
A Pilot Study of Unrelated Cord Blood (UCB) Transplantation and Unmatched Human Placental Derived Stem Cells (HPDSC) in Pediatric Malignant and Non-Malignant Disease
Cori Abikoff, MD, New York Medical College;
Qiuhu Shi, PhD, New York Medical College;
Roger Giller, MD, The Children's Hospital, Denver, University of Colorado School of Medicine;
Michael A. Pulsipher, MD, Primary Children's Medical Center, University of Utah School of Medicine;
Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC;
Shalini Shenoy, MD, Washington University, St. Louis Children's Hospital;
Theodore B Moore, MD, David Geffen School of Medicine at UCLA;
Lauren Harrison, RN, New York Medical College;
Erin Morris, RN, BSN, New York Medical College;
Olga Militano, PharmD, New York Medical College;
Janet Ayello, MS, MT(ASCP), New York Medical College;
Mildred Semidei-Pomales, MS, New York Medical College;
Sandra Foley, RN, MSN, CPNP, New York Medical College;
Xiaokui Zhang, PhD, Celgene Cellular Therapeutics;
Jodi Gurney, Celgene Cellular Therapeutics;
Jessica Hochberg, MD, New York Medical College;
Lee-Ann Baxter Lowe, PhD, University of California San Francisco;
Mitchell S. Cairo, MD, New York Medical College
Double-Unit Cord Blood (CB) Transplantation Combined with Haplo-Identical CD34+ Cells Results in 100% CB Engraftment with Enhanced Myeloid Recovery
Juliet N. Barker, MBBS, FRACP, Memorial Sloan-Kettering Cancer Center;
Doris M. Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Richard Meagher, PhD, Memorial Sloan-Kettering Cancer Center;
Hugo Castro-Malaspina, M.D., Memorial Sloan-Kettering Cancer Center;
Jenna D. Goldberg, MD, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, PhD MD, Memorial Sloan-Kettering Cancer Center;
Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center;
Craig Sauter, MD, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center
Prospective Evaluation of Alternative Donor Availability in 708 Patients: Improved Allograft Access with Enlarging Cord Blood (CB) Inventory for All Patients Including Racial and Ethnic Minorities
Parastoo Dahi, MD, Memorial Sloan-Kettering Cancer Center;
Doris M. Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Courtney Byam, BS, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Anne Marie Gonzales, BS, Memorial Sloan-Kettering Cancer Center;
Melissa Sideroff, BA, Memorial Sloan-Kettering Cancer Center;
Deborah Wells, MA, Memorial Sloan-Kettering Cancer Center;
Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
James W Young, MD, FACP, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Juliet N. Barker, MBBS, FRACP, Memorial Sloan-Kettering Cancer Center
KIR Haplotype Assigment By Next Generation Sequencing
Ketevan Gendzekhadze, PhD, City of Hope;
Lan-Feng Cao, MS, City of Hope;
Wyatt Nelson, PhD, Scisco;
Arisa Oki, MS, City of Hope;
Daniel Geraghty, PhD, Scisco;
David Senitzer, PhD, City of Hope
Impact of HLA Disparity with High-Resolution HLA Typing at HLA-a, -B, -C, and –DRB1 on Engraftment after Reduced Intensity Cord Blood Transplantation in Adults
Kazuya Ishiwata, MD, Toranomon Hospital;
Hisashi Yamamoto, MD, Toranomon Hospital;
Mitsuhiro Yuasa, Toranomon hospital;
Kosei Kageyama, Toranomon Hospital;
Daisuke Kaji, Toranomon Hospital;
Sachie Wada, Toranomon Hospital;
Hikari Ota, MD, Toranomon Hospital;
Masanori Tsuji, MD, Toranomon Hospital;
Go Yamamoto, MD, PhD, Toranomon Hospital;
Yuki Asano-Mori, MD, PhD, Toranomon Hospital;
Naoyuki Uchida, MD, Toranomon Hospital;
Koji Izutsu, MD, PhD, Toranomon Hospital;
Akiko Yoneyama, MD, PhD, Toranomon Hospital;
Shigeyoshi Makino, MD, PhD, Toranomon Hospital;
Shuichi Taniguchi, MD, PhD, Toranomon Hospital
High-Resolution Donor-Recipient HLA Matching Does Not Influence Acute or Chronic Gvhd in Umbilical Cord Blood Transplantation
Aleksandr Lazaryan, MD PhD, University of Minnesota;
John E. Wagner, MD, University of Minnesota;
Claudio Brunstein, MD, PhD, University of Minnesota;
Todd Defor, MS, University of Minnesota;
Margaret L. MacMillan, MD, MSc, University of Minnesota;
Bruce R. Blazar, MD, University of Minnesota;
Daniel J. Weisdorf, MD, University of Minnesota;
Mukta Arora, MD, MS, University of Minnesota
Outcomes of Double Unit Umbilical Cord Blood Transplantation Using Fludarabine/Busulfan Based Reduced Intensity Conditioning Regimen
Leonid Volodin, MD, University of Virginia School of Medicine;
Amer Beitinjaneh, MD, MPH, University of Virginia School of Medicine;
Huda Salman, MD, Georgia Regents Medical Center;
Mary J. Laughlin, MD, Cleveland Cord Blood Center;
Mark Smolkin, University of Virginia;
Hannah E. Spencer, MSc, University of Virginia School of Medicine;
Carlos G. Lee, University of Virginia;
Paige G. Williams, University of Virginia;
Kathlene DeGregory, BS pharmacy, PharmD, University of Virginia;
Tamila L Kindwall-Keller, DO, MS, University of Virginia School of Medicine
Comparative Analysis of T CELL Depleted Matched Vs Mismatched Unrelated DONOR Transplants in Patients with Hematologic Malignancies
Saliangi Wu, MD, Memorial Sloan Kettering Cancer Center;
Esperanza Papadopoulos, MD, Memorial Sloan-Kettering Cancer Center;
Molly Maloy, MS, Memorial Sloan-Kettering Cancer Center;
Patrick Hilden, PhD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Juliet Barker, MBBS (Hons) FRACP, Memorial Sloan-Kettering Cancer Center;
Hugo Castro-Malaspina, M.D., Memorial Sloan-Kettering Cancer Center;
Jenna D. Goldberg, MD, Memorial Sloan-Kettering Cancer Center;
Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center;
Doris M. Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Craig Sauter, MD, Memorial Sloan-Kettering Cancer Center;
Marcel R. M. van den Brink, MD, PhD, Memorial Sloan-Kettering Cancer Center;
James W Young, MD, FACP, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Ann A. Jakubowski, PhD, MD, Weill Medical College, Cornell University
Hemophagocytic Syndrome after Cord Blood Transplantation; Possible Implication of Severe Pre-Engraftment Immune Reactions
Hisashi Yamamoto, MD, Toranomon Hospital;
Shinsuke Takagi, Toranomon Hospital;
Naoyuki Uchida, MD, Toranomon Hospital;
Kosei Kageyama, Toranomon Hospital;
Daisuke Kaji, Toranomon Hospital;
Sachie Wada, Toranomon Hospital;
Aya Nishida, MD, Toranomon Hospital;
Hikari Ota, MD, Toranomon Hospital;
Kazuya Ishiwata, MD, Toranomon Hospital;
Masanori Tsuji, MD, Toranomon Hospital;
Go Yamamoto, MD, PhD, Toranomon Hospital;
Yuki Asano-Mori, MD, PhD, Toranomon Hospital;
Koji Izutsu, MD, PhD, Toranomon Hospital;
Atsushi Wake, MD, Toranomon Hospital;
Shuichi Taniguchi, MD, PhD, Toranomon Hospital
